NVX-508
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NVX-508, covering 2018-07-16 to 2018-07-16. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ib Study of NVX-508 in Sickle Cell Disease [Phase 1]